Satsuma Pharmaceuticals Inc. announced that Elisabeth Sandoval has been appointed as a member of the company's Board of Directors, effective immediately. Ms. Sandoval most recently served as Chief Commercial Officer and Executive Vice President of Corporate Strategy for Alder Biopharmaceuticals, and previously served as Chief Commercial Officer of KYTHERA Biopharmaceuticals. As Chief Commercial Officer and Executive Vice President of Corporate Strategy at Alder Biopharmaceuticals, Ms. Sandoval was responsible for developing and leading the company's commercial, strategy, medical affairs, investor relations, corporate communications and business development functions.